Top Cancer Stocks in China
Browse the largest China companies in the world ranked by their Market Capitalization. Global Cancer Companies in China market cap is $30.90B.
3 Sept 2024, 23:59 UTC
Companies: 37
🇨🇳1 |  | $6.29 | -2.49% | 5.29B | 4.81% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳2 |  | $6.63 | -0.40% | 2.98B | 12.72% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - |
🇨🇳3 |  | $21.11 | 0.37% | 2.67B | 61.06% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳4 |  | $5.28 | 0.11% | 2.15B | -21.55% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - |
🇨🇳5 |  | $7.94 | 0.69% | 2.10B | 7.05% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳6 |  | $4.99 | 3.50% | 2.09B | -31.32% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - |
🇨🇳7 |  | $2.51 | -3.31% | 1.59B | -45.00% | Underperform S&P500 YTD Benchamark | ⚕️ Healthcare | - |
🇨🇳8 |  | $4.51 | -0.85% | 1.25B | -28.31% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳9 | | $1.98 | -6.28% | 1.22B | -53.63% | Underperform S&P500 YTD Benchamark | ⚕️ Healthcare | - |
🇨🇳10 |  | $2.80 | 0.40% | 1.16B | -52.50% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳11 |  | $2.65 | 1.78% | 1.06B | -13.86% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳12 |  | $2.33 | -1.83% | 959.37M | -24.41% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳13 |  | $1.03 | -0.27% | 660.53M | -31.20% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳14 |  | $1.02 | 1.12% | 585.79M | -52.46% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳15 |  | $0.56 | -0.25% | 580.41M | -40.62% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - |
🇨🇳16 |  | $3.62 | 0.08% | 573.15M | -59.66% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳17 |  | $0.33 | 2.77% | 535.29M | -35.64% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳18 |  | $5.00 | -5.57% | 513.38M | 443.48% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳19 |  | $0.61 | 0.46% | 440.86M | -22.04% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - |
🇨🇳20 |  | $1.51 | 2.77% | 399.77M | -6.44% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳21 |  | $3.49 | 2.05% | 345.75M | -52.03% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - |
🇨🇳22 |  | $0.40 | -0.95% | 260.08M | -13.77% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳23 |  | $0.20 | -2.53% | 253.49M | -32.16% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳24 |  | $0.63 | 0.61% | 246.67M | -71.10% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳25 |  | $1.00 | -0.39% | 227.47M | -73.96% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳26 |  | $0.26 | 0.00% | 197.24M | 1.53% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳27 |  | $0.05 | 0.00% | 187.74M | -21.11% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳28 |  | $0.35 | -6.78% | 181.46M | -45.00% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳29 |  | $2.89 | 3.21% | 126.68M | 47.45% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳30 |  | $0.38 | -2.97% | 97.35M | -61.32% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳31 |  | $1.13 | 0.89% | 93.36M | -39.25% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳32 |  | $0.81 | -0.16% | 89.78M | -29.20% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳33 |  | $6.59 | 0.76% | 87.79M | -6.52% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳34 |  | $0.17 | 0.78% | 68.09M | -43.17% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳35 |  | $0.09 | 7.94% | 58.86M | -66.00% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳36 |  | $0.12 | 4.40% | 54.53M | -42.77% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳37 |  | $0.45 | 1.81% | 41.88M | -16.36% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
